Electrophysiological Data Needed To Determine ICD Benefit – NEJM Editorial
This article was originally published in The Gray Sheet
Executive Summary
The cost-effectiveness of expanded indications for implantable cardioverter defibrillators may pose a barrier to reimbursement by CMS, a New England Journal of Medicine editorial suggests